BACKGROUND: Coronary artery disease (CAD) risk is not fully revealed by traditional risk factors. Identification of a simple, noninvasive tool that allows for detection of high-risk CAD patients and can be applied in large populations and clinical settings would prove valuable. HYPOTHESIS: We sought to test the hypothesis that peripheral arterial tonometry (PAT) would be associated with residual risk in men with CAD. METHODS: In this study, finger PAT was used to measure pulse wave amplitude (PWA) during reactive hyperemia (RH) and taken as a measure of microvascular endothelial function in 42 men with stable CAD and well controlled low-density lipoprotein cholesterol (LDL-C) levels. Plasma levels of high-sensitivity C-reactive protein (hs-CRP) and lipoprotein-associated phospholipase A2 (Lp-PLA(2)) were measured and used to reclassify men into high-risk (elevated hs-CRP and Lp-PLA(2)), moderate-risk (either elevated hs-CRP or Lp-PLA(2)), or low-risk (low hs-CRP and Lp-PLA(2)) groups. RESULTS: PWA-RH was significantly lower in the high-risk group (1.3 +/- 0.04) compared to the moderate-risk (1.6 +/- 0.07, P < 0.05) and low-risk (2.0 +/- 0.1, P < 0.05) groups. According to binary logistic regression, PWA-RH was a significant predictor of high-risk status among men with CAD (P < 0.05). CONCLUSION: Measurement of peripheral microvascular endothelial function with PAT may be able to distinguish high-risk men from moderate- and low-risk men with stable CAD and well-controlled LDL-C levels and thus aid in residual risk stratification in this at risk cohort. Copyright 2010 Wiley Periodicals, Inc.
BACKGROUND:Coronary artery disease (CAD) risk is not fully revealed by traditional risk factors. Identification of a simple, noninvasive tool that allows for detection of high-risk CAD patients and can be applied in large populations and clinical settings would prove valuable. HYPOTHESIS: We sought to test the hypothesis that peripheral arterial tonometry (PAT) would be associated with residual risk in men with CAD. METHODS: In this study, finger PAT was used to measure pulse wave amplitude (PWA) during reactive hyperemia (RH) and taken as a measure of microvascular endothelial function in 42 men with stable CAD and well controlled low-density lipoprotein cholesterol (LDL-C) levels. Plasma levels of high-sensitivity C-reactive protein (hs-CRP) and lipoprotein-associated phospholipase A2 (Lp-PLA(2)) were measured and used to reclassify men into high-risk (elevated hs-CRP and Lp-PLA(2)), moderate-risk (either elevated hs-CRP or Lp-PLA(2)), or low-risk (low hs-CRP and Lp-PLA(2)) groups. RESULTS: PWA-RH was significantly lower in the high-risk group (1.3 +/- 0.04) compared to the moderate-risk (1.6 +/- 0.07, P < 0.05) and low-risk (2.0 +/- 0.1, P < 0.05) groups. According to binary logistic regression, PWA-RH was a significant predictor of high-risk status among men with CAD (P < 0.05). CONCLUSION: Measurement of peripheral microvascular endothelial function with PAT may be able to distinguish high-risk men from moderate- and low-risk men with stable CAD and well-controlled LDL-C levels and thus aid in residual risk stratification in this at risk cohort. Copyright 2010 Wiley Periodicals, Inc.
Authors: R B D'Agostino; M W Russell; D M Huse; R C Ellison; H Silbershatz; P W Wilson; S C Hartz Journal: Am Heart J Date: 2000-02 Impact factor: 4.749
Authors: Rajesh K Kharbanda; Benjamin Walton; Meredith Allen; Nigel Klein; Aroon D Hingorani; Raymond J MacAllister; Patrick Vallance Journal: Circulation Date: 2002-06-04 Impact factor: 29.690
Authors: Jeffrey T Kuvin; Ayan R Patel; Kathleen A Sliney; Natesa G Pandian; Jacob Sheffy; Robert P Schnall; Richard H Karas; James E Udelson Journal: Am Heart J Date: 2003-07 Impact factor: 4.749
Authors: Radjesh J Bisoendial; G Kees Hovingh; Johannes H M Levels; Peter G Lerch; Irmgard Andresen; Michael R Hayden; John J P Kastelein; Erik S G Stroes Journal: Circulation Date: 2003-05-27 Impact factor: 29.690
Authors: Piero O Bonetti; Gregory W Barsness; Paul C Keelan; Theresa I Schnell; Geralyn M Pumper; Jeffrey T Kuvin; Robert P Schnall; David R Holmes; Stuart T Higano; Amir Lerman Journal: J Am Coll Cardiol Date: 2003-05-21 Impact factor: 24.094
Authors: Christie M Ballantyne; Ron C Hoogeveen; Heejung Bang; Josef Coresh; Aaron R Folsom; Gerardo Heiss; A Richey Sharrett Journal: Circulation Date: 2004-02-02 Impact factor: 29.690
Authors: Heather Y Sun; Katie Jo Stauffer; Susan E Nourse; Chau Vu; Elif Seda Selamet Tierney Journal: Pediatr Cardiol Date: 2017-03-27 Impact factor: 1.655
Authors: Kevin S Heffernan; Jeffrey T Kuvin; Mark J Sarnak; Ronald D Perrone; Dana C Miskulin; Darya Rudym; Priya Chandra; Richard H Karas; Vandana Menon Journal: Nephrol Dial Transplant Date: 2011-02-03 Impact factor: 5.992
Authors: M van den Heuvel; O Sorop; P J Musters; R T van Domburg; T W Galema; D J Duncker; W J van der Giessen; K Nieman Journal: Neth Heart J Date: 2015-09 Impact factor: 2.380
Authors: Jennifer M MacRae; Sofia Ahmed; Brenda Hemmelgarn; Yichun Sun; Billie-Jean Martin; Idan Roifman; Todd Anderson Journal: Can J Kidney Health Dis Date: 2015-05-04
Authors: Morteza Naghavi; Stanley Kleis; Hirofumi Tanaka; Albert A Yen; Ruoyu Zhuang; Ahmed Gul; Yasamin Naghavi; Ralph Metcalfe Journal: Int J Vasc Med Date: 2022-01-06